Direkt zum Inhalt
Merck
  • Protective Efficacy of an Inactive Vaccine Based on the LY02 Isolate against Acute Haemophilus parasuis Infection in Piglets.

Protective Efficacy of an Inactive Vaccine Based on the LY02 Isolate against Acute Haemophilus parasuis Infection in Piglets.

BioMed research international (2015-12-22)
Xiao-Hua Li, Guo-Zhen Zhao, Long-Xin Qiu, Ai-Ling Dai, Wang-Wei Wu, Xiao-Yan Yang
ZUSAMMENFASSUNG

Haemophilus parasuis can cause Glässer's disease characterized by fibrinous polyserositis, polyarthritis, and meningitis. The current prevention of Glässer's disease is mainly based on the inactive vaccines; however, the protective efficacy usually fails in heterogeneous or homologous challenges. Here, the predominant lineage of H. parasuis (LY02 strain) in Fujian province, China, characterized as serovar 5, was used to evaluate the protective immunity against acute H. parasuis infection in piglets after inactivation. Following challenging with H. parasuis, only mild lesions in the pigs immunized with the killed vaccine were observed, whereas the typical symptoms of Glässer's disease presented in the nonimmunized piglets. A strong IgG immune response was induced by the inactive vaccine. CD4(+) and CD8(+) T lymphocyte levels were increased, indicating the potent cellular immune responses were elicited. The significantly high levels of IL-2, IL-4, TGF-β, and IFN-γ in sera from pigs immunized with this killed vaccine suggested that the mixed Th1 and Th2 immune responses were induced, associated with the high protection against H. parasuis infection compared to the nonimmunized animals. This study indicated that the inactivated LY02 strain of H. parasuis could serve as a potential vaccine candidate to prevent the prevalence of H. parasuis in Fujian province, China.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Sigma-Aldrich
Fluorescein, suitable for fluorescence, free acid
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, ≥95% (HPLC)
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, ≥99%
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, suitable for cell culture, ≥96.5% (HPLC), ≥96.5% (spectrophotometric assay), from yeast
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, Grade AA-1
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid, pkg of 10 mg (per vial)
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, ≥98%, BioUltra, from yeast
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid, pkg of 50 mg (per vial)
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid Hydrat, purified by column chromatography, ≥99%
Sigma-Aldrich
β-Nicotinamidadenin-Dinucleotid, pkg of 20 mg (per vial)
Sigma-Aldrich
β-Nicotinamide adenine dinucleotide lithium salt from Saccharomyces cerevisiae, ≥95%